「de」の検索結果
168件：21～25件目を表示
-
pan. MIEr for BeelineMED is capable of sharpening indistinct image files taken with various optical devices by installing image sharpening the algorithm developed by Logic and Design Co., Ltd. into el...
https://www.senju.co.jp/system/files/content_news/2025-02/ENG_20250220_0.pdf -
September 04, 2025 General Announcement: Senju Pharmaceutical Co., Ltd. Senju has developed and obtained approval for a BAC-free formulation of Aibeta® combination eye drops Senju Pharmaceutical Co., ...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904.pdf -
ry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a TRPV1 antagonist (development code: SJ...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117.pdf -
ミケランLA点眼液 添付文書 2022年3月改訂 TD75X2B17
なるMean blur rate （MBR） 値の有意な増加が認められた12） 。 19. 有効成分に関する理化学的知見 一般的名称：カルテオロール塩酸塩 〔Carteolol Hydrochloride （JAN） 〕 化学名：5- ［(2RS)-3-(1,1-Dimethylethyl)amino-2- hydroxypropyloxy］ -3,4-dihydroquinolin-2(1H)-...
https://www.senju.co.jp/system/files/product_other_file/2022-03/MKLA_17_20220330.pdf -
ry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a TRPV1 antagonist (development code: SJ...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf